Evidence map›Paper›PMID 40011844›Full record

ArticleMolecular medicine (Cambridge, Mass.)2025

Instantaneous dose rate as a crucial factor in reducing mortality and normal tissue toxicities in murine total-body irradiation: a comparative study of dose rate combinations.

Hongyu Zhu, Shihua Liu, Jiaqi Qiu, Ankang Hu, Wanyi Zhou, Jian Wang, Weihang Gu, Yinuo Zhu, Hao Zha, Rong Xiang and 5 more

Abstract readComparative Study
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hongyu Zhu *Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Yuexiu District, Guangzhou City, 510060, Guangdong province, China.
Shihua Liu *State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Jiaqi QiuBeijing Huaqingjia High Energy Electron Technology Corporation Limited, Beijing, 100091, China.
Ankang HuDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Wanyi ZhouDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Jian WangBeijing Huaqingjia High Energy Electron Technology Corporation Limited, Beijing, 100091, China.
Weihang GuDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Yinuo ZhuDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Hao ZhaDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Rong XiangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Junli LiDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Rui QiuDepartment of Engineering Physics, Tsinghua University, Beijing, 100084, China.
Chong ZhaoDepartment of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Peng HuangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Xiaowu DengDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Yuexiu District, Guangzhou City, 510060, Guangdong province, China. dengxw@sysucc.org.cn.

Funding

National Key R&D Program of China 2022YFC2402304National Natural Science Foundation of China 12305410
6 · The paper itself

Abstract

purposeThe ultra-high dose rate (UHDR) radiation shows promise in eradicating tumors while reducing normal tissue toxicities. However, the biological outcomes of UHDR are influenced by various factors, particularly the mean dose rate and instantaneous dose rate. Additionally, the UHDR response at large field sizes is lacking. This study aimed to explore the impact of different dose rate combinations on gastrointestinal biological outcomes following total-body irradiations (TBI) and to examine the involved molecular signaling pathways.

methodFemale C57BL6/J mice received 10 Gy TBI using three modes: ultra-high mean and ultra-high instantaneous dose rate irradiation (HH mode), low mean and ultra-high instantaneous dose rate irradiation (LH mode), and low mean and low instantaneous dose rate irradiation (LL mode). Mice were euthanized at 3 h and 48 h post irradiation to assess acute normal tissue damage and perform transcriptome sequencing. Furthermore, a subset of mice was monitored for 30 days to evaluate survival.

resultsWe found that when the instantaneous dose rate is sufficiently high (> 10

conclusionOur findings underscore the pivotal role of instantaneous dose rate in reducing radiation damages. When the instantaneous dose rate is sufficiently high (> 10

Indexed as

Radiation Injuries, ExperimentalWhole-Body IrradiationAnimalsDose-Response Relationship, RadiationFemaleMiceMice, Inbred C57BLTranscriptome

Identifiers

PMID40011844
PMCPMC11866584

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.